SCHEMBL4739738

SCHEMBL4739738

Cc1ccc(Nc2cc(=O)n(CCCCN3CCN(c4c(F)cc5c(=O)c(C(=O)O)c(C6CC6)[nH]c5c4F)CC3)c(=O)[nH]2)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4739730 0.94 — —
SCHEMBL4739686 0.90 — —
SCHEMBL6904722 0.87 — —
SCHEMBL6899561 0.86 — —
SCHEMBL6904667 0.86 — —
SCHEMBL6901659 0.85 — —
SCHEMBL4743074 0.84 — —
SCHEMBL6904980 0.84 — —
SCHEMBL6899572 0.84 — —
Hydrochloric Acid SCHEMBL6902139 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094203-A2 POLAR ESTER PRODRUGS OF HETEROCYCLIC HYBRID ANTIBACTERIAL COMPOUNDS AND SALTS THEREOF MICROBIOTIX, INC. (US) 2008-08-07 — — WO claimed
WO-2008094203-A2 POLAR ESTER PRODRUGS OF HETEROCYCLIC HYBRID ANTIBACTERIAL COMPOUNDS AND SALTS THEREOF MICROBIOTIX, INC. (US) 2008-08-07 — — WO disclosed
Send feedback